<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="table1-2050640620920157" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <p>Advice regarding patients on immunomodulators and biologics.</p>
 </caption>
 <alternatives>
  <graphic xlink:href="10.1177_2050640620920157-table1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <tbody valign="top">
    <tr>
     <td rowspan="1" colspan="1">General principles</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • Having IBD or liver disease is not a risk factor for COVID-19; 
      <break/>• the COVID-19 infection risk is similar in Crohn’s disease and ulcerative colitis;
      <break/> • patients should stay on their therapies and stay in remission.
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">General measures</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • Avoid contact with infected people;
      <break/> • avoid touching your eyes, nose or mouth with unwashed hands;
      <break/> • clean hands often by washing them with soap and water, for at least 20 seconds, and/or using an alcohol-based hand sanitizer that contains 60–95% alcohol.
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Travellers</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • IBD patients shall be discouraged from travelling; 
      <break/> • defer all cruise-ship travel worldwide;
      <break/> • avoid crowded places and long flights;
      <break/> • avoid close contact with people with acute respiratory infection and wash hands frequently.
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Medication and procedures</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • Keep ongoing immunomodulators; 
      <break/> • keep ongoing biologics; 
      <break/> • avoid prednisolone; 
      <break/> • reduce corticosteroids whenever possible; 
      <break/> • use masks in IV infusions units;
      <break/> • postpone elective endoscopic procedures and surgeries; 
      <break/> • postpone the start of immunomodulators and biologics unless active disease should prompt initiation.
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Close contact with someone with proven COVID-19 infection</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • Follow national recommendations, as any other person;
      <break/> • effects of treatment suspension are scarce;
      <break/> • do not stop medication.
     </td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">Patients in clinical trials</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1"> • Try to postpone the follow-up visit with the sponsor; 
      <break/> • phone calls and patient report outcomes (web-system);
      <break/> • home drug delivery;
      <break/> • local laboratories with email reports.
     </td>
    </tr>
   </tbody>
  </table>
 </alternatives>
</table-wrap>
